| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |